Market News & Trends
NJIT Researchers Unlock a New Method for Testing Protein-Based Drugs
New Jersey Institute of Technology researchers have unveiled a new lab technique they say represents a “paradigm shift” in how pharmaceutical laboratories test and produce…
BD Launches State-of-the-Art Cloud Software Solution to Streamline Flow Cytometry Research
BD (Becton, Dickinson and Company) recently launched BD® Research Cloud, a cloud-based software solution designed to streamline the flow cytometry workflow to enable higher….
Cornerstone Pharmaceuticals Initiates Phase 1 Trial of CPI-613 in Combination With Chemoradiation for the Treatment of Advanced Pancreatic Cancer
Cornerstone Pharmaceuticals, Inc. recently announced the initiation of a Phase 1 clinical trial evaluating CPI-613 (devimistat) in combination with chemoradiation for the treatment of advanced…
Cara Therapeutics Announces Difelikefalin Injection NDA Has Been Submitted in Japan
Cara Therapeutics, Inc. recently announced its licensing partner Maruishi Pharmaceutical Co., Ltd. submitted a New Drug Application (NDA) in Japan for approval of difelikefalin for…
KemPharm Announces Positive Topline Data from Phase 1 Clinical Trial Evaluating Cardiovascular Safety of Serdexmethylphenidate
KemPharm, Inc. recently announced topline data from its exploratory Phase 1 clinical trial confirming the relative cardiovascular effects and pharmacokinetics of serdexmethylphenidate (SDX) compared to…
Actylis Debuts, Signaling the Creation of an Integrated Global Specialty Ingredients Manufacturing & Sourcing Powerhouse
Actylis, a leading global manufacturer and sourcing expert of critical raw materials and performance ingredients for the life sciences and specialty chemicals markets, recently made its debut…..
Wheeler Bio Announces President & Chief Operating Officer
Wheeler Bio, a new CDMO specializing in the cell line development, process development, and small batch clinical production of antibodies, has announced the appointment of….
SCHOTT Pharma Expands Cartridge Production in China & Hungary
SCHOTT Pharma is again announcing plans to expand its manufacturing facilities: With a double-digit million Euro investment, the company aims to significantly increase its production…
Bora Pharmaceuticals Partners With TaiRx to Manufacture Breakthrough Anti-Cancer Drug
Bora Pharmaceutical Laboratories Inc., a division of Bora Pharmaceuticals, has partnered with TaiRx, Inc., a premier Taiwan new drug development company, to manufacture a novel anti-cancer drug, CVM-1118. ….
Clearmind Applies for Patent to Treat Obesity & Metabolic Syndrome
Clearmind Medicine Inc. recently announced it has filed a provisional patent application related to metabolic syndromes including obesity. The patent application is another result of…
Aptar Expands Pharmaceutical Services; Announces Exclusive Collaboration Between Aptar Pharma & Fluidda
Nanopharm, an Aptar Pharma company and leader in contract research and development services for orally inhaled and nasal drug products, recently announced an exclusive collaboration with Fluidda, a leader in the field of Functional Respiratory Imaging…..
Mapi Pharma Announces Positive Top-Line Results from GA Depot Phase 3 Trial for Relapsing Forms of Multiple Sclerosis
Mapi Pharma Ltd. recently announced positive top-line results from the GA Depot (a long acting glatiramer acetate) Phase 3 clinical trial assessing the efficacy, safety,…
Genelux Corporation Initiates Pivotal Phase 3 Trial Evaluating Olvi-Vec for the Treatment of Platinum-Resistant/Refractory Ovarian Cancer
Genelux Corporation recently announced it has initiated OnPrime, a multi-center, randomized, open-label Phase 3 registrational trial evaluating the efficacy and safety of Olvi-Vec in combination…
ProtaGene Names Pharmaceutical Industry Leader Raymond Kaiser as CEO to Drive Next Stages of Growth
ProtaGene GmbH recently announced the appointment of Raymond Kaiser, PhD, as Chief Executive Officer. Ray will drive the continued innovation….
Roquette Expands Global Reach of Plant-Based Excipients Portfolio With Complete Acquisition of Crest Cellulose
Roquette recently announced its complete acquisition of India-based excipient manufacturer, Crest Cellulose. Following its purchase of a majority share in the company in 2018, this latest move….
Immunic Announces Positive Results from Single & Multiple Ascending Dose Parts of its Phase 1 Clinical Trial
Immunic, Inc. recently announced positive unblinded safety, tolerability and pharmacokinetic (PK) results from Part A (single ascending doses, SAD) and Part B (multiple ascending doses, MAD)…
Decibel Therapeutics Announces Submission of IND Application for Lead Gene Therapy Candidate
Decibel Therapeutics recently announced the submission of an Investigational New Drug (IND) application to the US FDA for a Phase 1/2 clinical trial in pediatric…
Evoke Pharma Receives Notice of Allowance From USPTO for a Patent Related to GIMOTI
Evoke Pharma, Inc. recently announced the USPTO issued a Notice of Allowance for US Application No. 16/469,092 for GIMOTI. When granted, the patent will cover…
Merck Joins Accumulus Synergy as a Sponsor to Transform the Global Drug Regulatory Submission Process
Accumulus Synergy recently announced Merck, known as MSD outside the US and Canada, has joined Accumulus Synergy as a sponsor company…..
GENFIT to Acquire Clinical-Stage Biopharmaceutical Company, Expanding its Portfolio in Liver Diseases
GENFIT recently announced it has entered into an exclusivity agreement with a view to acquire all the share capital and voting rights of Versantis, a private…
